Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicinal compositon containing artemisine extract for treating rheumatoid arthritis and immunologic disease

A technology for immune diseases and rheumatoid diseases, which can be used in drug combinations, allergic diseases, bone diseases, etc., and can solve the problems of complex preparation, not fully satisfying clinicians and patients, and many Chinese patent medicines.

Inactive Publication Date: 2005-01-12
齐岩 +1
View PDF4 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The above-mentioned traditional Chinese medicine compositions are generally the conventional medicines of traditional Chinese medicine. When using them, doctors must formulate prescriptions according to the patient's condition according to the principle of syndrome differentiation and treatment of traditional Chinese medicine. There are also some Chinese patent medicines with many ingredients and complicated preparation, which cannot fully satisfy clinicians in practical application. and patient needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal compositon containing artemisine extract for treating rheumatoid arthritis and immunologic disease
  • Medicinal compositon containing artemisine extract for treating rheumatoid arthritis and immunologic disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] The pharmaceutical composition of the present invention is generally administered orally, and can also be administered in other ways, for example, external preparations can be used for the treatment of RA and autoimmune diseases with joint symptoms. The dosage is generally 1-10 mg / Kg body weight / day, and the dosage for adult patients is preferably 20-200 mg per person per day.

[0022] The preparation process of artemisinin or artemisinin derivatives (dihydroartemisinin, artesunate, artemether, artether) used in the present invention is known, and relevant preparation methods can be found in various literature reports.

[0023] The present invention can be further illustrated by the following experiments. But it should be noted that the experimental content of the present invention is only used to illustrate the present invention, rather than limit the present invention.

[0024] Effect of the pharmaceutical composition of the present invention on experimental general ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A composite medicine for treating the umatoid arthritis and autoimmune disease contains the sweet worm wood herb's extract (dihydroarteannuin, artesumate, artemether, etc).

Description

Technical field: [0001] The invention relates to a medicine for treating rheumatoid arthritis and autoimmune diseases accompanied by arthritis symptoms, in particular to a drug containing artemisinin or artemisinin for treating rheumatoid arthritis and autoimmune diseases accompanied by arthritis symptoms A pharmaceutical composition of artemisinin derivatives (dihydroartemisinin, artesunate, artemether, artemether, etc.). Background technique: [0002] Rheumatoid arthritis (hereinafter referred to as RA) is a kind of autoimmune disease, is a kind of worldwide systemic autoimmune disease of unknown cause, and its sickness rate is 0.4~1%, and its main feature is chronic , Symmetrical and diffuse synovitis of peripheral joints, various degrees of progressive joint destruction at the end, degeneration and loss of joint function, seriously affecting the patient's work and living ability, and causing a huge burden to the society. Other autoimmune diseases are usually accompanied...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/357A61P19/02A61P29/00A61P37/00
Inventor 齐岩宋靖钢
Owner 齐岩
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com